Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A choriocarcinoma of the central nervous system that occurs in an adult.
Biomarker and diagnostic research for adult central nervous system choriocarcinoma has been reported in the published literature.
No clinical trials have been registered for adult central nervous system choriocarcinoma.
8 publications have been identified in PubMed for adult central nervous system choriocarcinoma. Kisho has analyzed 6 by research type. Research spans Diagnostic / Biomarker (33%), Case Report / Case Series (33%), and Review / Meta-Analysis (17%).
Janssen FW (2026). [PMID: 41998312](https://pubmed.ncbi.nlm.nih.gov/41998312/). *Commun Med (Lond)*. [Diagnostic / Biomarker]
Bacon RL (2025). [PMID: 39692093](https://pubmed.ncbi.nlm.nih.gov/39692093/). *Vet Pathol*. [Case Report / Case Series]
Wang YF (2025). [PMID: 38821737](https://pubmed.ncbi.nlm.nih.gov/38821737/). *J Formos Med Assoc*. [Diagnostic / Biomarker]
Bouille F (2025). [PMID: 41272818](https://pubmed.ncbi.nlm.nih.gov/41272818/). *Acta Neuropathol Commun*. [Case Report / Case Series]
Bode PK (2025). [PMID: 39779499](https://pubmed.ncbi.nlm.nih.gov/39779499/). *Virchows Arch*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:54 AM UTC
Common questions about adult central nervous system choriocarcinoma
Abdulfatah E (2024). [PMID: 38697270](https://pubmed.ncbi.nlm.nih.gov/38697270/). *Hum Pathol*. [Basic Science / Preclinical]